Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Magellan Health, Inc. $400 Million Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of …
Zai Lab Limited Initial Public Offering and NASDAQ Listing
Davis Polk advised the joint book-running managers and representatives of the underwriters on the $172.5 million…
Healthcare Trust of America, Inc. $500 Million At-the-Market Offering
Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting…
Portola Pharmaceuticals Follow-On Offering
Davis Polk advised the joint book-running managers and the co-managers in connection with the $349.3 million…
Zoetis Inc. $1.25 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc…
Jazz Pharmaceuticals $500 Million Exchangeable Senior Notes Offering
Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned…
Oxford Immunotec Global PLC Offering of Ordinary Shares
Davis Polk advised the underwriter in connection with the $39.3 million SEC-registered offering of 2,500,000 ordinary…
BeiGene, Ltd. Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters on the $201 million public…
Celgene $500 Million Notes Offering
Davis Polk advised the sole book-running manager on an SEC-registered offering by Celgene Corporation of $500 million…
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5…